Barbara W Wollmer (Barbara Wollmer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 2

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Cancer prevention research (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Tracy M Downs, Howard H Bailey, Taja Lozar, Natalie S Schmitz, Heather Green, Cameron O Scarlett, Thomas C Havighurst, Kyleigh A Twaroski, Katina DeShong, Barbara W Wollmer, Trinity J Bivalacqua, Daniel R Saltzstein, Neal D Shore, KyungMann Kim, Wei Huang, William A Ricke, Lisa M Barroilhet, Margaret House, Howard L Parnes, Edward M Messing
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery. Cancer prevention research (Philadelphia, Pa.) (2024)
Jill M Kolesar, Shannon Andrews, Heather Green, Tom C Havighurst, Barbara W Wollmer, Katina DeShong, Douglas E Laux, Helen Krontiras, Donald D Muccio, KyungMann Kim, Clinton J Grubbs, Margaret G House, Howard L Parnes, Brandy M Heckman-Stoddard, Howard H Bailey
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers. Cancer prevention research (Philadelphia, Pa.) 12 (12) (2019)